Malaria No More UK

23/09/2026

Leading UK scientists have a warning: funding cuts to malaria research don't just stall progress overseas, they weaken the UK's own defences against future pandemics.

A survey of 35 UK-backed researchers found 80% believe malaria science directly benefits UK public health, and 80% say it makes the UK safer. Yet public funding for malaria R&D fell from $432m in 2021 to $351m in 2024, according to figures from .

Tomorrow we launch the full findings of The Malaria Science Index, produced with Imperial College London, the Liverpool School of Tropical Medicine - LSTM and Innovative Vector Control Consortium - the first study of its kind into the UK's malaria research leadership.

Read the Independent's coverage now: https://www.independent.co.uk/news/health/malaria-uk-pandemic-aid-cuts-science-b3054460.html



Image description: A screenshot of a tweet about the news article, overlaid on a video of scientists in Imperial College London's insectary

02/06/2026

A single-dose cure for malaria represents a major step forward. With malaria constantly evolving, climate-driven impacts reshaping communities at pace, and drug resistance continuing to rise, tools like those developed by our partner Medicines for Malaria Venture (MMV) are accelerating progress towards elimination, by making treatment shorter, simpler, and easier to complete.

We’re proud to have partnered with Medicines for Malaria Venture (MMV) to produce this animation highlighting how single-dose cure strengthens the ecosystem of interventions to end malaria.

With our current tools and future innovations, the possibility of ending malaria in our lifetime feels closer than ever. Tools like this are vital to sustaining momentum and moving us towards a malaria-free future.

01/06/2026

How can we better engage the UK public on an issue that affects us all: global health? How do we creatively communicate messages about health challenges like ending malaria in ways that truly connect with people?

These are some of the big questions we explored last week at our ‘Shaping the UK Conversation’ global health communications workshop. It was energising to be in a room full of creative, thoughtful, and brilliant experts from across the global health sector, sharing ideas on how we can better engage audiences and tell more powerful stories.

In an increasingly unpredictable political environment and fragmented media landscape, it is more important than ever that we think ahead, understand our audiences and work together around a shared message to highlight that malaria can be eliminated in our lifetime.

Zero Malaria Britain

28/05/2026

Join us! We’re looking for two brilliant new colleagues to be part of our dynamic ambitious team.

At Malaria No More UK, we exist to end malaria in our lifetime and we’re growing our team at an exciting moment for our mission – when there is a real possibility and opportunity to end the disease.

We’re looking for passionate, proactive and collaborative people to join us in driving impact through partnerships, fundraising, policy, research and advocacy.

We have two roles available, Fundraising Manager and Senior Policy and Research Manager.

You’ll be joining a small and ambitious team that consistently punches above its weight to deliver meaningful change in the fight against malaria.

Please click the link below to find out more

https://www.charityjob.co.uk/jobs/malaria-no-more-uk/senior-policy-and-research-manager/1068728

https://www.charityjob.co.uk/jobs/malaria-no-more-uk/fundraising-manager-corporate-partnerships/1068531

22/05/2026

Thank you to everyone we met at Foreign, Commonwealth & Development Office Global Partnerships Conference this week!

We shared discussions with decision makers, global partners, and health leaders about the future of the fight against .

Our malaria fighting toolboxes showcase the tools of today that control the disease, and the innovations of the future that can eliminate it.

Thank you Monica Harding, Éléonore Caroit French development minister, Fleur Anderson, David Miliband, Seema Malhotra, Andrew Mitchell, , Dianne Stewart - the global fund, Seb Meaney - Gavi for exploring the toolboxes with us, and for your support in our fight to reach

With innovations and tools developed by Innovative Vector Control Consortium (IVCC), London School of Hygiene & Tropical Medicine, University of Oxford, Jenner Institute University of Oxford, GSK & PATH, Medicines for Malaria Venture (MMV), FIND, diagnosis for all, Liverpool School of Tropical Medicine - LSTM, Imperial College London, University of Glasgow , Wellcome Trust - we are determined that together we can achieve a malaria-free world.

18/05/2026

Meet us at the Foreign, Commonwealth & Development Office Global Partnerships Conference this week co-hosted with Yvette Cooper and Children's Investment Fund Foundation.

We’re excited to joining global partners, health leaders and leading scientists to discuss the future of the fight against malaria.

In this changing world where we are facing diverse global health challenges, the conference is an opportunity to look at innovative financing, pioneering technology for health and leadership in creating solutions to global problems.

Visit us at the marketplace to explore our malaria toolboxes, which showcase the tools that control malaria today, and the innovations driving the fight to eliminate malaria for good.

Our brilliant Zero Malaria ambassador Sherrie Silver will also speak about why this fight against malaria matters and the drive behind her advocacy.

Join the conversation to build a malaria-free future together.

We will be showing innovations and tools developed by Innovative Vector Control Consortium (IVCC), London School of Hygiene & Tropical Medicine, University of Oxford, Jenner Institute University of Oxford, GSK & PATH, Medicines for Malaria Venture (MMV), FIND, diagnosis for all, Liverpool School of Tropical Medicine - LSTM, Target Malaria, Transmission Zero, University of Glasgow, Wellcome Trust

13/05/2026

This week, new research from The Lancet brought hopeful news in the fight against malaria.

The RTS,S malaria vaccine, now being rolled out in 25 countries, was found to reduce overall child deaths by 13% when delivered through routine immunisation programmes in Ghana, Kenya and Malawi. That's roughly 1 in 8 deaths averted among children in eligible age groups.

What makes this particularly significant is that these results came from real-world delivery, not controlled trials, and at coverage levels that weren't even complete. Around 70% of children received the first three doses. Imagine the impact if all children eligible received the vaccine.

Malaria killed an estimated 438,000 children under 5 in 2024. We have a vaccine that is working, and a whole toolbox of interventions that can control malaria. What we need now is commitment from decision makers to get them to every child who needs it.

Read more via London School of Hygiene & Tropical Medicine 👇

https://bit.ly/3R2TlII

Gavi, the Vaccine Alliance GSK

A malaria vaccine has been shown to reduce overall child deaths by 13% in routine use, according to a new study, providing the clearest evidence to date that vaccination against malaria can save lives

05/05/2026

“The scientific achievements of British academia are exceptional, and we should be celebrating them far more,” – Gareth Jenkins

As malaria threats grow due to climate change and antimicrobial resistance, the UK plays a central role in driving solutions in malaria research. It leads two of the three major mosquito genetic engineering programmes and has delivered two pioneering malaria vaccines.

With the UK as the world’s second-largest funder in malaria research, continued investment will undoubtedly drive economic growth, improve global health, and protect progress towards eliminating malaria.

The UK is driving pioneering malaria research in areas including genetic engineering, vaccines, and medicines. In Tanzania, the scientists involved tell Nick Ferris why research to tackle the disease and save lives is so important, particularly given the foreign aid cuts that are taking place global...

01/05/2026

We can . Not someday — but within our lifetimes.

UK-headquartered GSK are part of making that real. From the ongoing roll-out of their malaria vaccine, to cutting-edge research and development of new treatments to address resistance, reduce transmission in mosquitoes, and develop next-generation vaccines.

This is innovation that can truly lead to elimination.

Together, we're driven to end malaria. Now we can. Now we must.

29/04/2026

This year marks 15 years of partnership with longstanding supporter Rentokil Initial UK

Rentokil Initial. Their drive to end malaria has seen them contribute over £640,000 through our partnership. Thank you Rentokil Initial UK! "